Asset Details
Do you wish to reserve the book?
Postoperative statin treatment may be associated with improved mortality in patients with myocardial injury after noncardiac surgery
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Postoperative statin treatment may be associated with improved mortality in patients with myocardial injury after noncardiac surgery
Do you wish to request the book?
Postoperative statin treatment may be associated with improved mortality in patients with myocardial injury after noncardiac surgery
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Postoperative statin treatment may be associated with improved mortality in patients with myocardial injury after noncardiac surgery
2020
Overview
Myocardial injury after noncardiac surgery (MINS) is recently accepted as a strong predictor of mortality, regardless of symptoms. However, anticoagulation is the only established treatment. This study aimed to evaluate the association between statin treatment and mortality after MINS. From January 2010 to June 2019, a total of 5,267 adult patients who were discharged after the occurrence of MINS were enrolled. The patients were divided into two groups according to statin prescription at discharge. The outcomes were 1-year and overall mortalities. Of the total 5,109 patients, 1,331 (26.1%) patients were in the statin group and 3,778 (73.9%) patients were in the no statin group. The 1-year and overall mortalities were significantly lower in the statin group compared with the no statin group (6.1% vs. 13.3%; hazard ratio [HR], 0.55; 95% confidence interval [CI], 0.41–0.74; p < 0.001 for 1-year mortality and 15.0% vs. 25.0%; HR, 0.62; 95% CI, 0.51–0.76; p < 0.001 for overall mortality). Analyses after inverse probability treatment weighting showed similar results (HR, 0.61; 95% CI, 0.50–0.74; p < 0.001 for 1-year mortality and HR, 0.70; 95% CI, 0.54–0.90; p = 0.006 for overall mortality), and the mortalities did not differ according to the dose of statin. Our results suggest that statin treatment may be associated with improved survival after MINS. A trial is needed to confirm this finding and establish causality.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 692/499
/ 692/53
/ Adult
/ Aged
/ Anticoagulants - therapeutic use
/ Female
/ Heart Injuries - prevention & control
/ Humanities and Social Sciences
/ Humans
/ Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
/ Male
/ Myocardial Infarction - etiology
/ Myocardial Infarction - mortality
/ Myocardial Infarction - prevention & control
/ Myocardial Ischemia - etiology
/ Myocardial Ischemia - mortality
/ Myocardial Ischemia - prevention & control
/ Patients
/ Postoperative Complications - mortality
/ Postoperative Complications - prevention & control
/ Science
/ Statins
/ Surgery
